B2-agonists
B2-agonists
Long-acting bronchodilators (LABD) are similar in structure to short-acting selective beta2-adrenoceptor agonists, but have much longer side chains resulting in a 12-hour effect, and are used to give symptomatic relief.
Editor's Choice
Recent estimates suggest that worldwide more than 5 million people die each year from smoking, which equates to one death every six seconds....
The Impact of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Chronic obstructive pulmonary disease (COPD) is complicated by recurrent acute exacerbations. These exacerbations are...
Latest News
28th October 2009 -
Older Patients With Dementia At Increased Risk For Flu Mortality
27th October 2009 -
Re-launched TeamCOPD.ca Website Profiles COPDers And Supporters And Showcases The Coast 2 Coast Challenge Event
27th October 2009 -
Post-Storm Conditions In Philippines Continue To Threaten Health
26th October 2009 -
Latest Analysis Confirms Suboptimal Vitamin D Levels In Millions Of US Children
